
Juan Jose Gonzalez
@juanjgonmd
Gastroenterology & Transplant Hepatology Fellow @UFHepGastro 💩🐊 | Photophile 📸 | @MSUMD & @UJMD_sv alumnus | Salvadoran 🇸🇻🇺🇸 | T/RT=My Own
ID: 316023200
https://www.researchgate.net/profile/Juan-Gonzalez-352/research 12-06-2011 20:34:00
3,3K Tweet
776 Followers
834 Following

It’s always fun times working with 🌟Elliot Tapper Thanks to ClinicalLiverDisease for letting us highlight the importance of managing muscle cramps in #cirrhosis #livertwitter

Do muscle cramps in your patients with cirrhosis have you in a pickle?! Never fear, Juan Jose Gonzalez and Elliot Tapper have the answers! A detailed but yet concise overview: journals.lww.com/cld/fulltext/2…



How can AI 🤖 assist w remote monitoring in hepatic encephalopathy🤔 @hevargasmd and I discuss two very important AJG - The American Journal of Gastroenterology articles that leverage AI-📱 app 📸 of 💩 to assist with #HE therapy! #LiverTwitter #DigitalHealth journals.lww.com/ajg/citation/9…


❔Why do some patients develop ascites after liver transplantation? ✨Learn from Juan Jose Gonzalez about post-transplant ascites including how to evaluate and why we care! #livertwitter #GITwitter #MedEd #FOAMed aasld.org/liver-fellow-n…



⌚️Emerging #Digital Technologies to Help Patients with Cirrhosis📱 ‼️ ✅out this review in AASLD ClinicalLiverDisease where Tiffany Wu, MD MS and I discuss how digital tools are reshaping #liver care! #LiverTwitter journals.lww.com/cld/fulltext/2…




I couldn’t agree more with Hanna Blaney, MD, MPH Every new start on this journey should come with an IS reminder that YOU DESERVE to be here! #GIFellowship #MedTwitter #IMG

We had a blast welcoming our new fellows! Thanks to our incredible PD GingerClarkMD for hosting 🌟🐊


Our amazing PD GingerClarkMD discussing alpha-1 antitrypsin deficiency: -Liver steatosis is common in AATD -Survival is limited after cirrhosis diagnosis -Fazirsiran on phase 3 trial for AATD with fibrosis Rare disease but important cause of illness and disability


🌟Cynthia Levy, MD discussing PBC: - UDCA works but <80% treated with it. Hispanics has less response to UDCA - OCA greater TFS compared to non external controls - Elafibranor has arrived. Seladelpar next? - Chronic itching and fatigue management priority!


🚨 Introducing Gator Gut Buster: Myth or Fact? 🐊 Your new go-to for gastroenterology & hepatology truths! This month’s myth: Correcting coagulation factors before paracentesis is a must. ❌ Myth! Post by our IM resident Hannah Zuercher, MD #GITwitter #livertwitter


Check out this recently published image of the month at Gastro Hep Advances 👇 Hannah Zuercher, MD is a rockstar and I have no doubt she will be an amazing GI fellow! 🌟💩 #LiverTwitter #MedTwitter UF Gastroenterology & Hepatology ghadvances.org/article/S2772-…

👏👏👏to this all 🌟crew of Liver Fellow Network ! Richie Manikat Beverly Kyalwazi Sarah Uttal @chipsbowman @mianbkhalid Juan Jose Gonzalez Lindsay Matthews @NabeelWahidMD Adam Mikolajczyk Alessandro Gambella



Appreciate the highlight! Thank you Resham Ramkissoon, MD! Liver Fellow Network Hanna Blaney, MD, MPH Elliot Tapper Juan Jose Gonzalez VCU Stravitz-Sanyal Institute for Liver Disease

One of the best places in the U.S. for a second chance. ✅ 99.6% 1y survival ✅ 24 days waiting time ✅ 15/15 SRTR bars, again ✅ 83% lower mortality risk FLORIDA UF Health ASTS Florida Dept. of Health AASLD United Network for Organ Sharing (UNOS) Donate Life America
